血管生成拟态与大肠癌肝转移相关性探究

外科研究与新技术 ›› 2016, Vol. 5 ›› Issue (3): 162-164,172.

血管生成拟态与大肠癌肝转移相关性探究

张文忠,凌杰,徐斌,邱伟,王永兵

上海市浦东新区人民医院普通外科

收稿日期:2016-07-14 修回日期:2016-08-08 出版日期:2016-09-28 发布日期:2016-10-27
通讯作者: 王永兵 E-mail:wwybw@sina.com
基金资助:
上海市浦东新区卫生计生委科技项目;上海市浦东新区卫生计生委科技项目

Study of Correlation of vasculogenic mimicry and liver metastasis of colorectal cancer

Received:2016-07-14 Revised:2016-08-08 Online:2016-09-28 Published:2016-10-27

摘要/Abstract

摘要： 目的探讨血管生成拟态（vasculogenic mimicry, VM）与大肠癌肝转移相关性。方法免疫组织化学染色观察115例大肠癌患者癌组织中VM的生成情况，其中伴有肝转移患者25例，无肝转移患者90例。调查回访手术后2年中这115例大肠癌患者的复发和肝转移状况。结果手术前伴有肝转移的患者中64.0%的患者VM为阳性，而无肝转移组仅有26.7%为VM阳性。无肝转移的患者手术后2年内复发和肝转移的发生与VM的生成相关性具有统计学意义，P值分别为0.0003和小于0.0001。结论 VM与大肠癌的复发及肝转移成正相关。

关键词: 大肠癌, 血管生成拟态, 肝转移

Abstract: Objective Explore the relationship between vasculogenic mimicry and liver metastasis of colorectal cancer. Methods Analysis of vasculogenic mimicry formation in 115 colorectal carcinoma patients by immunohistochemical staining. Among the colorectal carcinoma patients, 25 were with liver metastases and 90 without liver metastases. Monitor cancer recurrence and liver metastases of these 115 patients by surveying for 2 years. Restults Among patients with liver metastases, 64.0% were VM positive. While only 26.7% were VM positive among patients without liver metastases. Recurrence and liver metastases of patients without liver metastases before operation were statistically significant with VM existence with the P values of 0.0003 and less than 0.0001, respectively. Conclusion VM was positively associated with recurrence and liver metastases of colorectal cancer.

Key words: colorectal cancer, vasculogenic mimicry, liver metastasis

张文忠凌杰徐斌邱伟王永兵. 血管生成拟态与大肠癌肝转移相关性探究[J]. 外科研究与新技术, 2016, 5(3): 162-164,172.

参考文献

[1]Maniotis AJ, Folberg R, Hess A, et al.Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry[J].Am J Pathol, 1999, 155(3):739-752 [2]Paulis YM, Soetekouw PM, Verheul HM, et al.Signalling pathways in vascullogenic mimicry[J].Biochim Biophys Acta, 2010, 1806(1):18-28 [3]Qiao LL, Liang N, Zhang JD, et al.advanced research on vasculogenic mimicry in cancer[J].J Cell Mol Med, 2015, 19(2):315-326 [4]Spiliopoulos K, Peschos D, Batistatou A, et al.Vasculogenic mimicry: lessons from melanocytic tumors[J].In Vivo, 2015, 29(3):309-317 [5]Folberg R, Maniotis AJ.Vasculogenic mimicry[J].APMIS, 2004, 112(7-8):508-525 [6]Hao X, Sun B, Zhang S, et al.Microarray study of vasculogenic mimicry in bi-directional differentiation malignant tumor [J][J].Zhonghua Yi Xue Za Zhi, 2002, 82(19):1298-1302 [7]Baeten CI, Hillen F, Pauwels P, et al.Prognostic role of vasculogenic mimicry in colorectal cancer[J].Dis Colon Rectum, 2009, 52(12):2028-2035 [8]Li Y, Sun B, Zhao X, et al.Subpopulations of uPAR+ contribute to vasculogenic mimicry and metastasis in large cell lung cancer[J].Exp Mol Pathol, 2015, 98(2):136-144 [9]Sood AK, Seftor EA, Fletcher MS, et al.Molecular determinants of ovarian cancer plasticity[J].Am J Pathol, 2001, 158(4):1279-1288 [10]Tu DG, Yu Y, Lee CH, et al.Hinokitiol inhibits vasculogenic mimicry activity of breast cancer stemprogenitor cells through proteasome-mediated degradation of epidermal growth factor receptor[J].Oncol Lett, 2016, 11(4):2934-2940 [11]Shirakawa K, Wakasugi H, Heike Y, et al.Vasculogenic mimicry and pseudo-comedo formation in breast cancer[J].Int J Cancer, 2002, 99(6):821-828 [12]Mao JM, Liu J, Guo G, et al.Glioblastoma vasculogenic mimicry: signaling pathways progression and potential anti-angiogenesis targets[J].Biomark Res, 2015, 18(3):8-17 [13]Cai Xuansong, Jia Yongwei, Mei Jiong, et al.Tumor blood vessels formation in osteosarcoma: vasculogenesis mimicry[J].Chin J Med, 2004, 117(1):94-98 [14]Luo F, Yang K, Liu RL, et al.Formation of vasculogenic mimicry in bone metastasis of prostate cancer: correlation with cell apoptosis and senescence regulation pathways[J].Pathol Res Pract, 2014, 210(5):291-295 [15]Ahmadi SA, Moinfar M, Gohari Moghaddam K, et al.Practical application of angiogenesis and vasculogenic mimicry in prostatic adenocarcinoma[J].Arch Iran Med, 2010, 13(6):498-503 [16]Sharma N, Seftor RE, Seftor EA, et al.Prostatic tumor cell plasticity involves cooperative interactions of distinct phenotypic subpopulations: role in vasculogenic mimicry[J].Prostate, 2002, 50(3):189-201 [17]范跃祖, 孙伟, 张文忠, 等.原发性胆囊癌患者肿瘤血管生成拟态及其临床意义[J].中华医学杂志, 2007, 87(3):145-149 [18]陈万青, 郑荣寿, 张思维.年中国恶性肿瘤发病和死亡分析[J].中国肿瘤, 2016, 25(1):1-8 [19] 汤钊猷.现代肿瘤学 [M]. 第二版. 上海：上海医科大学出版社，2000，775-818. [20]施东华，王小林.大肠癌肝转移机制及诊治进展[J].中国医学计算机成像杂志, 2010, 16(1):81-86 [21]赵景松.不同部位大肠癌肝转移分布的临床研究[J].肿瘤, 2001, 21(1):61-62 [22]王俊，顾玉明.血管生成拟态在肝癌中的研究进展[J].当代医学, 2012, 18(6):112-115 [23]Cao Z, Bao M, Miele L, et al.Tumour vasculogenic mimicry is associated with poor prognosis of human cancer patients: a systemic review and meta-analysis[J].Eur J Cancer, 2013, 49(18):3914-3923 [24]Liu R, Yang K, Meng C, et al.Vasculogenic mimicry is a marker of poor prognosis in prostate cancer[J].Cancer Biol Ther, 2012, 13(7):527-533 [25]Chen YS, Chen ZP.vasculogenic mimicry: a novel target for glioma therapy[J].Chin J Cancer, 2014, 33(2):74-79 [26]Fan YZ, Sun W.molecular regulation of vasculogenic mimicry in tumors and potential tumor-target therapy[J].World J Gastrointest surg, 2010, 2(4):117-127 [27] Hendrix MJ, Seftor EA, Seftor RE, et al.Tumor cell vascular mimicry: Novel targeting opportunity in melanoma [J].[J].Pharmacol Ther, 2016, 159(3):83-92